Common Contracts

9 similar Employment Agreement contracts by Karuna Therapeutics, Inc., Cogent Biosciences, Inc., Xeris Biopharma Holdings, Inc., Vericel Corp

EMPLOYMENT AGREEMENT
Employment Agreement • May 8th, 2025 • Vericel Corp • Biological products, (no disgnostic substances) • Massachusetts

This Employment Agreement (“Agreement”) is entered into between Vericel Corporation, a Michigan corporation (the “Company”) and Karen Mahoney (the “Executive”), effective as of July 25, 2024, unless another date is agreed to by the Executive and the Company (the “Effective Date”).

Contract
Employment Agreement • August 2nd, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • Delaware
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • July 8th, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • Delaware

This Second Amended and Restated Employment Agreement (“Agreement”) is made as of July 7, 2024, by and among Xeris Biopharma Holdings, Inc., a Delaware corporation (the “Parent”), Xeris Pharmaceuticals, Inc., a Delaware corporation and wholly-owned subsidiary of the Parent (the “Company”), and John Shannon (the “Executive”) and is effective as of August 1, 2024 (the “Effective Date”)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • February 26th, 2024 • Cogent Biosciences, Inc. • Pharmaceutical preparations • Massachusetts

This Amended and Restated Employment Agreement (“Agreement”) is made between Cogent Biosciences, Inc., a Delaware corporation (the “Company”), and Evan D. Kearns (the “Executive”) as of December 20, 2021 (the “Effective Date”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • February 22nd, 2024 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and William Kane (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • February 22nd, 2024 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Second Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and Steven Paul, M.D. (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • November 2nd, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and Jason Brown (the “Executive”) and is made effective as of September 29, 2023 (the “Effective Date”).

EMPLOYMENT AGREEMENT
Employment Agreement • May 4th, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and William Kane (the “Executive”) and is entered into on January 20, 2023 and made effective as of February 6, 2023 (the “Effective Date”).

EMPLOYMENT AGREEMENT
Employment Agreement • November 9th, 2020 • Cogent Biosciences, Inc. • Pharmaceutical preparations • Colorado

This Employment Agreement (“Agreement”) is made between Cogent Biosciences Inc., a Delaware corporation (the “Company”), and Andrew Robbins (the “Executive”).